The microfluidic devices market size has grown rapidly in recent years. It will grow from $10.14 billion in 2025 to $11.72 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to limited microfabrication techniques, high cost of early microfluidic devices, reliance on traditional fluid handling methods, growing pharmaceutical and biotech research, adoption of basic lab-on-a-chip applications.
The microfluidic devices market size is expected to see rapid growth in the next few years. It will grow to $20.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to advancements in microfabrication and 3D printing, rising demand for point-of-care diagnostics, integration of sensors and actuators with microfluidic platforms, increasing investment in precision medicine research, expansion of high-throughput screening applications. Major trends in the forecast period include rising adoption of lab-on-a-chip and digital microfluidic devices, integration of advanced microfluidic sensors for diagnostics, increased use of microfluidic platforms in pharmaceutical research, growth in polymer and silicon-based microfluidic materials, enhanced focus on miniaturization and high-throughput fluid handling.
The rising prevalence of infectious diseases is increasingly supporting the expansion of the microfluidic devices market going forward. Infectious diseases are caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, and their prevalence is influenced by environmental conditions, pathogen characteristics, human behavior, and access to healthcare services. Microfluidic devices play a vital role in infectious disease management by enabling precise handling and analysis of small biological samples, improving detection accuracy, and supporting efficient diagnosis and monitoring. For example, in November 2025, according to the European Centre for Disease Prevention and Control, a Sweden-based government agency, 266,165 chikungunya virus disease cases and 118 related deaths were reported globally in 2025. Consequently, the rising prevalence of infectious diseases is strengthening demand for microfluidic devices.
Leading companies operating in the microfluidic devices market are focused on developing innovative platforms, such as microfluidic chip-based systems, to automate complex laboratory processes, improve experimental precision, and support diverse applications. A microfluidic chip-based platform integrates multiple laboratory functions on a single miniaturized chip to precisely control and analyze small fluid volumes. For example, in January 2023, SCIEX, a US-based manufacturer of mass spectrometry instrumentation, launched the Intabio ZT system, the first fully integrated microfluidic chip-based platform combining imaged capillary isoelectric focusing separation with UV detection. The system incorporates Biologics Explorer software, which enhances data processing and supports deeper characterization of biopharmaceutical samples.
In January 2025, bioMérieux, a France-based biotechnology company, acquired SpinChip Diagnostics for an undisclosed amount. With this acquisition, bioMérieux aims to strengthen and accelerate its growth in the point-of-care diagnostics segment, particularly in immunoassays for acute care settings. SpinChip Diagnostics is a Europe-based company specializing in microfluidic diagnostic devices.
Major companies operating in the microfluidic devices market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Technologies Incorporated, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Zeon Corporation, Standard BioTools Inc., Biosurfit SA, Blacktrace Holdings Ltd., LioniX International B.V., CMC Microsystems Inc., Micronit Microfluidics B.V., Sphere Fluidics Limited, Microfluidic ChipShop GmbH, BlackHole Lab Inc., Bartels-Mikrotechnik GmbH, Hesperos Inc., Fluigent SA.
North America was the largest region in the microfluidic devicess market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the microfluidic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microfluidic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microfluidic devices market by increasing costs for imported microchips, sensors, and specialized polymers used in device fabrication. Segments like digital microfluidic chips and microfluidic analytical devices are particularly affected, with Asia-Pacific regions including China, Taiwan, and India facing significant import duties. This has led to increased production costs and supply chain realignments. On the positive side, tariffs are encouraging local manufacturing, fostering innovation in alternative materials, and supporting investment in domestic high-precision microfabrication capabilities.
The microfluidic devices market research report is one of a series of new reports that provides microfluidic devices market statistics, including microfluidic devices industry global market size, regional shares, competitors with a microfluidic devices market share, detailed microfluidic devices market segments, market trends and opportunities, and any further data you may need to thrive in the microfluidic devices industry. This microfluidic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Microfluidic devices are tools that control and manipulate extremely small fluid volumes on miniature chips, enabling precise fluid movement through microchannels for applications in diagnostics, research, and chemical processing.
The key device categories of microfluidic devices include chips, sensors, and others. Microfluidic chips are compact devices containing networks of channels, chambers, and wells that control and direct fluid flow at a microscale level. The materials used include glass, silicon, polymer, and others, and these devices are utilized by end users such as pharmaceutical and biotechnology companies, research institutes, diagnostic centers, healthcare facilities, and others.
The microfluidic devices market consists of sales of microchannels, microvalves, and microelectrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The microfluidic devices market size is expected to see rapid growth in the next few years. It will grow to $20.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to advancements in microfabrication and 3D printing, rising demand for point-of-care diagnostics, integration of sensors and actuators with microfluidic platforms, increasing investment in precision medicine research, expansion of high-throughput screening applications. Major trends in the forecast period include rising adoption of lab-on-a-chip and digital microfluidic devices, integration of advanced microfluidic sensors for diagnostics, increased use of microfluidic platforms in pharmaceutical research, growth in polymer and silicon-based microfluidic materials, enhanced focus on miniaturization and high-throughput fluid handling.
The rising prevalence of infectious diseases is increasingly supporting the expansion of the microfluidic devices market going forward. Infectious diseases are caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, and their prevalence is influenced by environmental conditions, pathogen characteristics, human behavior, and access to healthcare services. Microfluidic devices play a vital role in infectious disease management by enabling precise handling and analysis of small biological samples, improving detection accuracy, and supporting efficient diagnosis and monitoring. For example, in November 2025, according to the European Centre for Disease Prevention and Control, a Sweden-based government agency, 266,165 chikungunya virus disease cases and 118 related deaths were reported globally in 2025. Consequently, the rising prevalence of infectious diseases is strengthening demand for microfluidic devices.
Leading companies operating in the microfluidic devices market are focused on developing innovative platforms, such as microfluidic chip-based systems, to automate complex laboratory processes, improve experimental precision, and support diverse applications. A microfluidic chip-based platform integrates multiple laboratory functions on a single miniaturized chip to precisely control and analyze small fluid volumes. For example, in January 2023, SCIEX, a US-based manufacturer of mass spectrometry instrumentation, launched the Intabio ZT system, the first fully integrated microfluidic chip-based platform combining imaged capillary isoelectric focusing separation with UV detection. The system incorporates Biologics Explorer software, which enhances data processing and supports deeper characterization of biopharmaceutical samples.
In January 2025, bioMérieux, a France-based biotechnology company, acquired SpinChip Diagnostics for an undisclosed amount. With this acquisition, bioMérieux aims to strengthen and accelerate its growth in the point-of-care diagnostics segment, particularly in immunoassays for acute care settings. SpinChip Diagnostics is a Europe-based company specializing in microfluidic diagnostic devices.
Major companies operating in the microfluidic devices market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Technologies Incorporated, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Zeon Corporation, Standard BioTools Inc., Biosurfit SA, Blacktrace Holdings Ltd., LioniX International B.V., CMC Microsystems Inc., Micronit Microfluidics B.V., Sphere Fluidics Limited, Microfluidic ChipShop GmbH, BlackHole Lab Inc., Bartels-Mikrotechnik GmbH, Hesperos Inc., Fluigent SA.
North America was the largest region in the microfluidic devicess market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the microfluidic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microfluidic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microfluidic devices market by increasing costs for imported microchips, sensors, and specialized polymers used in device fabrication. Segments like digital microfluidic chips and microfluidic analytical devices are particularly affected, with Asia-Pacific regions including China, Taiwan, and India facing significant import duties. This has led to increased production costs and supply chain realignments. On the positive side, tariffs are encouraging local manufacturing, fostering innovation in alternative materials, and supporting investment in domestic high-precision microfabrication capabilities.
The microfluidic devices market research report is one of a series of new reports that provides microfluidic devices market statistics, including microfluidic devices industry global market size, regional shares, competitors with a microfluidic devices market share, detailed microfluidic devices market segments, market trends and opportunities, and any further data you may need to thrive in the microfluidic devices industry. This microfluidic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Microfluidic devices are tools that control and manipulate extremely small fluid volumes on miniature chips, enabling precise fluid movement through microchannels for applications in diagnostics, research, and chemical processing.
The key device categories of microfluidic devices include chips, sensors, and others. Microfluidic chips are compact devices containing networks of channels, chambers, and wells that control and direct fluid flow at a microscale level. The materials used include glass, silicon, polymer, and others, and these devices are utilized by end users such as pharmaceutical and biotechnology companies, research institutes, diagnostic centers, healthcare facilities, and others.
The microfluidic devices market consists of sales of microchannels, microvalves, and microelectrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Microfluidic Devices Market Characteristics
3. Microfluidic Devices Market Supply Chain Analysis
4. Global Microfluidic Devices Market Trends and Strategies
5. Microfluidic Devices Market Analysis of End Use Industries
7. Global Microfluidic Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Microfluidic Devices Total Addressable Market (TAM) Analysis for the Market
9. Microfluidic Devices Market Segmentation
10. Microfluidic Devices Market Regional and Country Analysis
11. Asia-Pacific Microfluidic Devices Market
12. China Microfluidic Devices Market
13. India Microfluidic Devices Market
14. Japan Microfluidic Devices Market
15. Australia Microfluidic Devices Market
16. Indonesia Microfluidic Devices Market
17. South Korea Microfluidic Devices Market
18. Taiwan Microfluidic Devices Market
19. South East Asia Microfluidic Devices Market
20. Western Europe Microfluidic Devices Market
21. UK Microfluidic Devices Market
22. Germany Microfluidic Devices Market
23. France Microfluidic Devices Market
24. Italy Microfluidic Devices Market
25. Spain Microfluidic Devices Market
26. Eastern Europe Microfluidic Devices Market
27. Russia Microfluidic Devices Market
28. North America Microfluidic Devices Market
29. USA Microfluidic Devices Market
30. Canada Microfluidic Devices Market
31. South America Microfluidic Devices Market
32. Brazil Microfluidic Devices Market
33. Middle East Microfluidic Devices Market
34. Africa Microfluidic Devices Market
36. Microfluidic Devices Market Competitive Landscape and Company Profiles
37. Microfluidic Devices Market Other Major and Innovative Companies
40. Microfluidic Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Microfluidic Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses microfluidic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microfluidic devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microfluidic devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Chips; Sensors; Other Device Types2) By Material: Glass; Silicon; Polymer; Other Materials
3) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Diagnostic Centers; Healthcare Facilities; Other End-Users
Subsegments:
1) By Chips: Lab-On-A-Chip (LoC) Devices; Digital Microfluidic Chips; Microfluidic Flow Control Chips; Integrated Microfluidic Platforms; Diagnostic Microfluidic Chips2) By Sensors: Pressure Sensors; Flow Sensors; Temperature Sensors; Chemical Sensors; Optical Sensors
3) By Other Device Types: Microfluidic Pumps; Valves And Actuators; Microarray Devices; Microfluidic Analytical Devices; Microfluidic Bioreactors
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; Teledyne Technologies Incorporated; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Zeon Corporation; Standard BioTools Inc.; Biosurfit SA; Blacktrace Holdings Ltd.; LioniX International B.V.; CMC Microsystems Inc.; Micronit Microfluidics B.V.; Sphere Fluidics Limited; Microfluidic ChipShop GmbH; BlackHole Lab Inc.; Bartels-Mikrotechnik GmbH; Hesperos Inc.; Fluigent SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Microfluidic Devices market report include:- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Teledyne Technologies Incorporated
- Illumina Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Zeon Corporation
- Standard BioTools Inc.
- Biosurfit SA
- Blacktrace Holdings Ltd.
- LioniX International B.V.
- CMC Microsystems Inc.
- Micronit Microfluidics B.V.
- Sphere Fluidics Limited
- Microfluidic ChipShop GmbH
- BlackHole Lab Inc.
- Bartels-Mikrotechnik GmbH
- Hesperos Inc.
- Fluigent SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.72 Billion |
| Forecasted Market Value ( USD | $ 20.65 Billion |
| Compound Annual Growth Rate | 15.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
